Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
about
Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisCharacterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasisIdentification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics AnalysisEvaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral LeishmaniasisComparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.Identifying vaccine targets for anti-leishmanial vaccine developmentVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesTh1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis.Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani.Vaccine Development Against Leishmania donovani.Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster.Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.Immunoprophylactic Potential of a Cocktail of Three Low Molecular Weight Antigens of Leishmania donovani along with Various Adjuvants Against Experimental Visceral leishmaniasis.
P2860
Q28483976-FFA3D9F4-2954-4F02-AC9F-29B19958CFB9Q28539119-0A855D3C-1488-4942-A5B0-43CA82EA5F70Q28550337-845041E1-5DB0-4AD9-8C5B-C7D4A31B3758Q31060208-5D7CCEB6-0D54-496D-9045-6F7137CD2610Q33615236-A574A7E2-C3B1-4838-9377-9A17394D30A8Q33693899-685C03C5-790D-4E73-AA6C-5650B9421914Q34076804-F02EC27E-51FA-4561-BC9E-426C0319A06EQ34277331-A76685B3-16D5-4272-84EE-3C84898FA41DQ34314499-73B3D98F-E0DA-467C-9E30-3D5C5CDE4A41Q36211636-DDC3DD9A-1DE9-40B7-9890-1A075E5F3275Q36712429-3A20D7C9-194F-4AE3-8BBE-C43549BF0F9EQ38012112-7506093A-E0F4-4C72-A723-FD47B9501E6AQ40141972-F54AD9B1-18B6-4010-99C4-95DAB86DD707Q40783439-9083D1F1-9754-4106-9C35-F9140A2A42C6Q41603970-7ACB038A-CAB3-440D-B82A-21B7F2C6D795Q44606808-06AD611A-3092-4384-A34A-EC77A8BE9E94Q46290224-2C194F4E-8ACF-4B27-9A59-ABF0F91C8464Q47232128-12514C02-7792-455D-912A-DE5B28680512Q55405901-ED177E1A-EFC2-4609-B9EA-F7018E70A96F
P2860
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@ast
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@en
type
label
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@ast
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@en
prefLabel
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@ast
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@en
P2093
P1433
P1476
Th1-stimulatory polyproteins o ...... mental visceral leishmaniasis.
@en
P2093
Ajit K Shasany
Anuradha Dube
Brijesh Sisodia
Mukesh Samant
Pragya Misra
Shraddha Kumari
P304
P356
10.1016/J.VACCINE.2008.08.021
P407
P577
2008-08-30T00:00:00Z